Clinical trial
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received…
NCT00210639 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00210639 |
|---|---|
| Title | A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection |
| Official title | A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Musculoskeletal Diseases |
| Intervention type | Drug |
| Interventions | No intervention |
| Enrollment | 2,233 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 21, 2014 |
| Countries | Argentina, Brazil, Chile, Costa Rica, Israel, Mexico, Panama, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: